Hepatitis B infection in Libya: The magnitude of the problem.



Abdul-Naser Elzouki.

Department of Medicine, Aljamahyria Teaching Hospital, Faculty of Medicine, Al-arab Medical University, Benghazi, Libya.

Libyan J Infect Dis. Vol. 2, No.1. Jan-2008:20-25


Chronic infection with hepatitis B virus (HBV) affects more than 400 million people worldwide, and it is estimated that up to one million people die annually from HBV-related disease. Chronic HBV is the leading cause of cirrhosis and hepatocellular carcinoma worldwide, and high levels of HBV replication have been associated with progressive liver disease. Between 15% and 40% of chronically infected patients will go on to experience liver disease progression. New epidemiological data on hepatitis B have been published in the last few years from Libya. These include the results of the general population-based nationwide seroprevalence survey of this infection, risk factors and genotyping. In this short review, we will discuss the update of magnitude of hepatitis B infection in Libya.

Keywords: Epidemiology, genotyping, hepatitis B virus, infection, Libya, natural history

Link/DOI: http://www.nidcc.org.ly/reports/THE%20LIBYAN%20JOURNAL%20OF%20%20Infectious%20Diseases%20V2%20%20No%201/3%20Hepatitis%20B%20infection%20in%20Libya.pdf